The Role of Osteopontin in Angiogenesis
Book:
Recent Advances in Angiogenesis and Antiangiogenesis
Page:
10-19
Author(s):
Daria Leali and Antonella Naldini
Tachykinergic System and Binding Molecules in Disease: Implication for Targeted Therapies
Book:
Frontiers in CNS Drug Discovery
Page:
378-389
Author(s):
Pranela Rameshwar
Targeting Vesicle Trafficking in Cancer Therapeutics
Book:
Frontiers in Anti-Cancer Drug Discovery
Page:
758-776
Author(s):
Paul K. Wright
The Anti-Cancer Charm of Flavonoids: A Cup-of-Tea Will Do You Good!
Book:
Frontiers in Anti-Cancer Drug Discovery
Page:
552-587
Author(s):
Amr Amin and Michael Buratovich
Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment, a 2009 Update
Book:
Frontiers in Anti-Cancer Drug Discovery
Page:
380-427
Author(s):
Sui Xiong Cai
Aurora Kinase Family: A New Target for Anticancer Drug
Book:
Frontiers in Anti-Cancer Drug Discovery
Page:
132-148
Author(s):
Teresa Macarulla, M. Elena Elez, Francisco Javier Ramos and Josep Tabernero
Histone Deacetylase Inhibitors in Cancer Therapy
Book:
Frontiers in Anti-Cancer Drug Discovery
Page:
79-115
Author(s):
Alfredo Budillon, Francesca Bruzzese and Elena Di Gennaro
Ginsenoside Rg3 and Rh2: The Anti-Cancer and Anti- Angiogenic Saponins from Ginseng
Book:
Anti-Angiogenesis Drug Discovery and Development
Page:
34-57
Author(s):
Patrick Y.K. Yue, Y. Huang and Ricky N.S. Wong
Organophosphate Toxicity Relating to Exposure Route and Type of Agent
Book:
Chemical-Induced Seizures: Mechanisms, Consequences and Treatment
Page:
39-48
Author(s):
Marloes J.A. Joosen, Marcel J. van der Schans, August B. Smit and Herman P.M. van Helden
Index
Book:
Molecular Mechanism and Morphology in Cancer
Page:
138-144
Author(s):
Misa Nakamura and Kennichi Kakudo